tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
with an average price target of $10.3. This is a potential upside of $10.3 (0%) from yesterday's end of day stock price of $0.
Concert Pharmaceuticals's activity chart (see below) currently has 74 price targets and 51 ratings on display.
Analysts average stock forecasts to be materialized ratio is 20.5% with an average time for these price targets to be met of 245.3 days.
Most recent stock forecast was given by STEPHEN KIM from EVERCORE on 20-Jan-2023. First documented stock forecast 07-Jul-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$17
2 years 9 months 6 days ago
(20-Jan-2023)
0/1 (0%)
$10.12 (147.09%)
Buy
$25
2 years 9 months 7 days ago
(19-Jan-2023)
0/6 (0%)
$18.01 (257.65%)
Buy
$17
$8.63 (103.11%)
$17
3 years 5 months 3 days ago
(22-May-2022)
1/6 (16.67%)
$12.9 (314.63%)
115
Buy
$10
$1.63 (19.47%)
$15
3 years 11 months 14 days ago
(11-Nov-2021)
0/3 (0%)
$6 (150.00%)
Buy
$9
4 years 18 days ago
(07-Oct-2021)
3/10 (30%)
$6.09 (209.28%)
392
What is CNCE (Concert Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on CNCE (Concert Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CNCE (Concert Pharmaceuticals)?
Which analyst is the currently most bullish on CNCE (Concert Pharmaceuticals)?
Which analyst is the currently most reserved on CNCE (Concert Pharmaceuticals)?
